title: Metformin and diabetic kidney disease: a mini-review on recent findings.
abstract: Metformin, an oral anti-diabetic agent in the biguanide class is a widely prescribed drug to treat high blood glucose in patients with type 2 diabetes mellitus. Metformin has three different roles, including blood glucose regulatory effect, protection of kidney tubular cell by acting as an effective antioxidant and finally ameliorative effect on diabetic kidney disease through saving the podocytes. Therefore, diabetic patients may benefit from all of these three distinct ameliorative effects.
authors: Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan.
authors: Hamid
authors: H
authors: Nasri
authors: Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
authors: Mahmoud
authors: M
authors: Rafieian-Kopaei
keywords: Anti-diabetic Agents; Diabetes; Kidney Disease; Metformin